When expression of CDK5 was measured by immunohistochemical staining of a tissue microarray with more than 200 cases of primary cancer, we found that patients with high CDK5 expression, particularly expression in the cytoplasm have poor overall survival using Kaplan-Meier survival analysis (Fig 6B and S1 Table). Here, CDK5 is linked to cancer.